From a new way to treat diabetes via an old tuberculosis vaccine to the impact on the industry of increasing patient volumes, each week we highlight the latest in life sciences. … READ MORE >
5 things to know in life sciences: Week of June 21
From a new generation of deep brain stimulation devices to using artificial intelligence to detect HIV, each week we highlight five things you need to know about in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of June 14
From tools to support decentralized clinical trials to new efforts to reduce systemic racism in medical research, each week we highlight five things you need to know about in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of June 7
From the new Alzheimer’s drug, aducanumab, to a White House report on supply chain risk, we highlight the latest impacting the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of May 31
From a new clinical trial service launched by CVS to sequencing the entire human genome, we highlight the latest trends impacting the life sciences industry this week. … READ MORE >
5 things to know in life sciences: Week of May 24
This week we highlight the 340B drug pricing program, oncology clinical trials, balancing patient privacy concerns with data needs for artificial intelligence and more. … READ MORE >
5 things to know in life sciences: Week of May 17
This week we highlight a new report on COVID-19 trials and diversity; functional service providers; biopharma, drug pricing and ESG scores; and more. … READ MORE >
5 things to know in life sciences: Week of May 10
This week we highlight small-company drug launches during the pandemic, the future of the biopharma office, using artificial intelligence to diagnose rare diseases and more. … READ MORE >
5 things to know in life sciences: Week of May 3
This week we highlight herd immunity challenges, concerns about waiving patent protections on COVID-19 vaccines, using machine learning to reduce trial risks and more. … READ MORE >
5 things to know in life sciences: Week of April 26
This week we highlight why people may be skipping their second COVID-19 dose, challenges of AI in patient diagnosis, the evolution of the regulatory environment for biopharma companies and more. … READ MORE >